STOCK TITAN

ALT5 Sigma Reports 114% Year-Over-Year Increase in Transaction Volume for the Month of July 2024

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

ALT5 Sigma (NASDAQ:ALTS), a fintech company specializing in blockchain-powered technologies for digital assets, has reported a 114% year-over-year increase in transaction volume for July 2024. The company's transaction volume reached US$179 million in July 2024, up from $84 million in July 2023. ALT5's year-to-date transaction volume stands at $1.05 billion, representing a 101% year-over-year increase.

Chief Revenue Officer Vay Tham noted that the company typically experiences an uptick in transaction volume during the second half of the fiscal year. ALT5 Sigma continues to focus on growth and expanding its solutions to a wider range of organizations in its core markets.

ALT5 Sigma (NASDAQ:ALTS), un'azienda fintech specializzata in tecnologie basate su blockchain per asset digitali, ha riportato un incremento del 114% anno su anno nel volume delle transazioni per luglio 2024. Il volume delle transazioni dell'azienda ha raggiunto 179 milioni di dollari USA a luglio 2024, rispetto ai 84 milioni di dollari a luglio 2023. Il volume delle transazioni da inizio anno di ALT5 ammonta a 1,05 miliardi di dollari, con un incremento del 101% anno su anno.

Il Chief Revenue Officer Vay Tham ha osservato che l'azienda solitamente registra un aumento del volume delle transazioni durante la seconda metà dell'anno fiscale. ALT5 Sigma continua a concentrarsi sulla crescita e sull'espansione delle proprie soluzioni a una platea più ampia di organizzazioni nei suoi mercati principali.

ALT5 Sigma (NASDAQ:ALTS), una empresa fintech especializada en tecnologías impulsadas por blockchain para activos digitales, ha reportado un aumento del 114% interanual en el volumen de transacciones para julio de 2024. El volumen de transacciones de la compañía alcanzó 179 millones de dólares en julio de 2024, en comparación con 84 millones de dólares en julio de 2023. El volumen de transacciones acumulado en el año de ALT5 es de 1,05 mil millones de dólares, representando un aumento del 101% interanual.

El Director de Ingresos Vay Tham señaló que la empresa típicamente experimenta un aumento en el volumen de transacciones durante la segunda mitad del año fiscal. ALT5 Sigma continúa enfocándose en el crecimiento y en la expansión de sus soluciones a un rango más amplio de organizaciones en sus mercados clave.

ALT5 시그마 (NASDAQ:ALTS)는 디지털 자산을 위한 블록체인 기반 기술을 전문으로 하는 핀테크 기업으로, 2024년 7월 거래량이 전년 대비 114% 증가했다고 보고했습니다. 이 회사의 거래량은 2024년 7월에 1억 7900만 달러에 도달했으며, 2023년 7월의 8400만 달러에서 증가했습니다. ALT5의 연간 누적 거래량은 10억 5000만 달러로, 전년 대비 101% 증가를 나타냅니다.

Vay Tham 최고 수익 책임자는 회사가 일반적으로 회계 연도 하반기에 거래량이 증가한다고 언급했습니다. ALT5 Sigma는 성장에 집중하고 있으며, 핵심 시장의 더 넓은 범위의 조직에 솔루션을 확장하고 있습니다.

ALT5 Sigma (NASDAQ:ALTS), une entreprise fintech spécialisée dans les technologies basées sur la blockchain pour les actifs numériques, a annoncé une augmentation de 114 % d'une année sur l'autre de son volume de transactions pour juillet 2024. Le volume de transactions de l'entreprise a atteint 179 millions de dollars US en juillet 2024, contre 84 millions de dollars en juillet 2023. Le volume de transactions d'ALT5 depuis le début de l'année s'élève à 1,05 milliard de dollars, représentant une augmentation de 101 % d'une année sur l'autre.

Le directeur des revenus Vay Tham a noté que l'entreprise connaît généralement une hausse de son volume de transactions au cours de la seconde moitié de l'exercice fiscal. ALT5 Sigma continue de se concentrer sur la croissance et l'expansion de ses solutions à un plus grand nombre d'organisations dans ses marchés clés.

ALT5 Sigma (NASDAQ:ALTS), ein Fintech-Unternehmen, das sich auf blockchainbasierte Technologien für digitale Vermögenswerte spezialisiert hat, hat einen 114%igen Anstieg des Transaktionsvolumens im Jahresvergleich für Juli 2024 gemeldet. Das Transaktionsvolumen des Unternehmens erreichte im Juli 2024 179 Millionen US-Dollar, ein Anstieg von 84 Millionen US-Dollar im Juli 2023. Das bisherige Transaktionsvolumen von ALT5 liegt bei 1,05 Milliarden US-Dollar, was einen 101%igen Anstieg im Jahresvergleich darstellt.

Vay Tham, Chief Revenue Officer, stellte fest, dass das Unternehmen normalerweise in der zweiten Hälfte des Geschäftsjahres einen Anstieg des Transaktionsvolumens verzeichnet. ALT5 Sigma konzentriert sich weiterhin auf Wachstum und die Erweiterung seiner Lösungen für eine breitere Palette von Organisationen in seinen Kerng Märkten.

Positive
  • 114% year-over-year increase in transaction volume for July 2024
  • Transaction volume reached US$179 million in July 2024
  • Year-to-date transaction volume of $1.05 billion, a 101% year-over-year increase
  • Consistent growth trend observed over the past four years
Negative
  • None.

ALT5 Sigma's impressive 114% YoY growth in transaction volume for July 2024 signals robust momentum in the digital asset space. The $179 million volume, up from $84 million last year, indicates strong market demand for their blockchain-powered solutions. With a YTD volume of $1.05 billion, representing a 101% YoY increase, ALT5 is demonstrating consistent growth. This performance suggests the company is successfully capitalizing on the expanding digital asset market. However, investors should note that transaction volume doesn't directly translate to revenue or profit. It's important to see how this growth impacts ALT5's financial statements in upcoming earnings reports to gauge the true financial health of the company.

ALT5 Sigma's substantial growth underscores the increasing adoption of blockchain technology in financial services. Their comprehensive suite, covering tokenization, trading, clearing, settlement and custody, positions them well in the evolving digital asset ecosystem. The 114% YoY increase suggests their technology is gaining traction, potentially due to improved scalability, security, or user experience. However, the crypto market's volatility could be a factor in this growth. It's important to consider how ALT5's technology differentiates from competitors and adapts to regulatory changes. The company's ability to maintain this growth trajectory will depend on continuous innovation and addressing potential scalability challenges as transaction volumes surge.

The significant growth in ALT5 Sigma's transaction volume reflects broader trends in the digital asset market. The 114% YoY increase outpaces the general crypto market growth, suggesting ALT5 is gaining market share. The company's focus on institutional clients could be a key driver, as more traditional financial entities explore digital asset integration. The mention of historical seasonality with stronger second-half performance is noteworthy; if this pattern holds, we could see even higher volumes in coming months. However, it's important to monitor regulatory developments, as they can significantly impact market dynamics. Investors should also consider how ALT5's growth compares to competitors to assess their relative market position and long-term potential in this rapidly evolving sector.

LAS VEGAS, NV / ACCESSWIRE / August 13, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, released its transaction volume for July 2024.

According to the company, ALT5's transaction volume exceeded US$179 million for the month of July 2024, which represents a year-over-year increase of 114% from the $84 million recorded in July 2023. ALT5's year-to-date transaction volume is $1.05 billion, which represents a year-over-year increase of 101%.

July 2024

July 2023

July 2022

July 2021

$179,352,052

$83,810,993

$47,264,497

$26,582,621

"Based on historical seasonality that we have experienced over the last few years, the second half of the fiscal year traditionally sees an uptick in transaction volume. We are pleased with the year-over-year growth and encouraged by the month-over-month increase in business as well," said Vay Tham, Chief Revenue Officer of ALT5 Sigma Corporation. "We continue to focus on growth and providing our solutions to an expanding set of organizations in our core markets," further added Mr. Tham.

About ALT5 Sigma

The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.

Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US$1.2 billion in cryptocurrency transactions in 2023.

ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.

Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.

Forward Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.

Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Media Contact Investor Relations

IR@alt5sigma.com
1-800-400-2247

Contact Information

Investor Relations
Investor Relations
ir@alt5sigma.com
1-800-400-2247

SOURCE: ALT 5 Sigma Corp.



View the original press release on accesswire.com

FAQ

What was ALT5 Sigma's (ALTS) transaction volume for July 2024?

ALT5 Sigma's transaction volume for July 2024 was US$179,352,052.

How much did ALT5 Sigma's (ALTS) transaction volume increase year-over-year in July 2024?

ALT5 Sigma's transaction volume increased by 114% year-over-year in July 2024 compared to July 2023.

What is ALT5 Sigma's (ALTS) year-to-date transaction volume for 2024?

ALT5 Sigma's year-to-date transaction volume for 2024 is $1.05 billion.

Who is the Chief Revenue Officer of ALT5 Sigma (ALTS)?

The Chief Revenue Officer of ALT5 Sigma is Vay Tham.

ALT5 Sigma Corporation

NASDAQ:ALTS

ALTS Rankings

ALTS Latest News

ALTS Stock Data

29.95M
12.77M
0.8%
4.97%
0.37%
Software - Application
Pharmaceutical Preparations
Link
United States of America
LAS VEGAS